Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators

Basso, 2009, Arrhythmogenic right ventricular cardiomyopathy, Lancet, 373, 1289, 10.1016/S0140-6736(09)60256-7 Calkins, 2013, Arrhythmogenic right ventricular dysplasia, Curr Probl Cardiol, 38, 103, 10.1016/j.cpcardiol.2012.12.002 Wichter, 2007, Risk stratification and antiarrhythmic drug therapy, 171 Corrado, 2003, Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circulation, 108, 3084, 10.1161/01.CIR.0000103130.33451.D2 Rougin, 2004, Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy, J Am Coll Cardiol, 43, 1843, 10.1016/j.jacc.2004.01.030 Peters, 2007, Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres, J Cardiovasc Med, 8, 521, 10.2459/01.JCM.0000278450.35107.b3 Pezawas, 2006, Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up, Int J Cardiol, 107, 360, 10.1016/j.ijcard.2005.03.049 Buja, 2008, Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy, Prog Cardiovasc Dis, 50, 282, 10.1016/j.pcad.2007.10.004 Proclemer, 2009, Use of implantable cardioverter-defibrillator in inherited arrhythmogenic disease: data from Italian ICD Registry for the Years 2001-6, Pace, 32, 434, 10.1111/j.1540-8159.2009.02302.x Corrado, 2010, Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia, Circulation, 122, 1144, 10.1161/CIRCULATIONAHA.109.913871 Bhonsale, 2011, Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention, J Am Coll Cardiol, 58, 1485, 10.1016/j.jacc.2011.06.043 Ellenbogen, 2006, for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (Definite) Investigators. Are implantable cardioverter fibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?, Circulation, 113, 776, 10.1161/CIRCULATIONAHA.105.561571 Connolly, 2006, Use and misuse of surrogate outcomes in arrhythmia trials, Circulation, 113, 764, 10.1161/CIRCULATIONAHA.105.600668 Marcus, 2009, Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study, Heart Rhythm, 6, 984, 10.1016/j.hrthm.2009.03.013 Marcus, 2010, Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria, Circulation, 121, 1533, 10.1161/CIRCULATIONAHA.108.840827 Pinamonti, 2011, Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry, Eur Heart J, 32, 1105, 10.1093/eurheartj/ehr040 Cox, 2011, Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study, Circulation, 123, 2690, 10.1161/CIRCULATIONAHA.110.988287 McKenna, 1994, Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy, Br Heart J, 71, 215, 10.1136/hrt.71.3.215 Leclercq, 1991, Long-term follow-up after sustained monomorphic ventricular tachycardia: causes, pump failure, and empiric antiarrhythmic therapy that modify survival, Am Heart J, 121, 1685, 10.1016/0002-8703(91)90013-8 Canu, 1993, Prognostic et évolution à long terme de la dysplasia arythmogène du ventricule droit [Prognosis and long-term development of arrhythmogenic dysplasia of the right ventricle], Arch Mal Cœur, 86, 41 Hulot, 2004, Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy, Circulation, 110, 1879, 10.1161/01.CIR.0000143375.93288.82 Wichter, 2005, Arrhythmogenic right ventricular cardiomyopathy, Herz, 30, 91, 10.1007/s00059-005-2677-6 Bhonsale, 2013, Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers, Circ Arrhythm Electrophysiol, 6, 569, 10.1161/CIRCEP.113.000233 te Riele, 2013, Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated desmosomal mutation carriers, J Am Coll Cardiol, 62, 1761, 10.1016/j.jacc.2012.11.087 Olde Nordkamp, 2013, The ICD for primary prevention in patients with inherited cardiac diseases, Circ Arrhythm Electrophysiol, 6, 91, 10.1161/CIRCEP.112.975268 Schinkel, 2013, Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy, Circ Arrhythm Electrophysiol, 6, 562, 10.1161/CIRCEP.113.000392 Garcia, 2009, Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circulation, 120, 366, 10.1161/CIRCULATIONAHA.108.834903 Sacher, 2010, Epicardial ventricular tachycardia ablation, J Am Coll Cardiol, 55, 2366, 10.1016/j.jacc.2009.10.084 Yamada, 2013, Transthoracic epicardial catheter ablation: indications, techniques, and complications, Circ J, 77, 1672, 10.1253/circj.CJ-13-0510 James, 2013, Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers, J Am Coll Cardiol, 62, 1290, 10.1016/j.jacc.2013.06.033 Link, 2014, Ventricular arrhythmias in the North American Multidisciplinary Study of ARVC, J Am Coll Cardiol, 64, 119, 10.1016/j.jacc.2014.04.035 Marcus, 2009, for the Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy, J Am Coll Cardiol, 54, 609, 10.1016/j.jacc.2009.04.052